Organization
Johns Hopkins Univ School of Medicine, Baltimore, MD, United States
1 abstract
Abstract
ABATACEPT IMPROVES FATIGUE, ACTIVITY LIMITATION AND QUALITY OF LIFE IN METHOTREXATE-NAÏVE PATIENTS WITH EARLY RA AND POOR PROGNOSTIC FACTORS Org: UZ Gasthuisberg, KU Leuven, Leuven, Belgium, Klinikum Eilbek, Hamburg, Germany, Johns Hopkins Univ School of Medicine, Baltimore, MD, United States, Institut de Rhumatologie de Montreal, Montreal, QC, Canada, Bristol-Myers Squibb, Princeton, NJ, United States,